OLUWADAYO ADEYEMO: Open Payments
NPI 1669961504 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 44 payments from 9 companies in 2025. Trend: 2023 $557 · 2024 $262 · 2025 $1,031
Food & beverage: $1,002Education: $29
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $262 |
| E.R. Squibb & Sons, L.L.C. | 4 | $203 |
| ABBVIE INC. | 12 | $161 |
| Vanda Pharmaceuticals Inc. | 4 | $99 |
| Corium, LLC | 7 | $89 |
| Axsome Therapeutics, Inc. | 4 | $89 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: COBENFY, INGREZZA, VRAYLAR, FANAPT, Azstarys, Auvelity, AUSTEDO XR, Qelbree.
Industry payments across TX — which companies pay providers there.
